Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
📜 Formula
Xuezhikang Capsule; Xue Zhi Kang Capsule
1
Clinical Trials
3
Meta-Analyses
2
PubMed References
Top Conditions Studied with Xuezhikang Capsule; Xue Zhi Kang Capsule
📋 Sample Trials
NCT02057302
A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia
Completed · Phase 4
📊 Sample Meta-Analyses
CRD42017062739
Chinese patent medicine for hyperlipidemias: a network meta-analysis of randomized controlled trials
Hyperlipidemias, including hypercholesterolemia, hyperlipoproteinemias, hypertri
CRD42017062486
Lipid-lowering effect of Xuezhikang capsule for patients with coronary heart disease combined with hyperlipidemia: protocol for a systematic review
Dyslipidemia is a risk for cardiovascular disease. Statins can cut down the leve
CRD42019132518
Xuezhikang capsule for hypercholesterolaemia: a systematic review and meta-analysis of randomized clinical trials
Hypercholesterolemia is a condition characterized by high levels of cholesterol
📚 Sample References
PMID 29921884
Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules
Acta Pharmacol Sin · 2018
PMID 36126782
The effect of Xuezhikang capsule on gene expression profile in brown adipose tissue of obese spontaneously hypertensive rats
J Ethnopharmacol · 2023
📜 All Formula data fields for Xuezhikang Capsule; Xue Zhi Kang Capsule
📜 Names
Pinyin Name
Xuezhikang Jiaonang
中文名 (Chinese)
血脂康胶囊
English Name
Xuezhikang Capsule; Xue Zhi Kang Capsule
💊 Form & Use
Category
Chinese patent medicines
Dosage Form
胶囊剂 (Capsule)
Administration
Oral
Source / 出处
Chinese Pharmacopoeia 2020 edition
🌿 Composition
Herbs (中文)
红曲
Herbs (Pinyin)
Hong Qu
🩺 Syndromes & Indications
Syndromes (中文)
化浊降脂，活血化瘀，健脾消食
Indications (中文)
用于痰阻血瘀所致的高脂血症，症见气短、乏力、头晕、头痛、胸闷、腹胀、食少纳呆；也可用于高脂血症及动脉粥样硬化所致的其他的心脑血管疾病的辅助治疗
Indications (English)
Used for hyperlipidemia caused by phlegm and blood stasis, symptoms such as shortness of breath, fatigue, dizziness, headache, chest tightness, abdominal distension, lack of appetite and appetite; it can also be used for hyperlipidemia and other heart caused by atherosclerosis Adjuvant treatment of cerebrovascular diseases
🔗 External References
HERB DB
ITCM
53054
🔍 Raw view — every non-empty column on this row (27 fields)
name
Xuezhikang Capsule; Xue Zhi Kang Capsule
pinyin name
Xuezhikang Jiaonang
chinese name
血脂康胶囊
english name
Xuezhikang Capsule; Xue Zhi Kang Capsule
formula id str
HBFO005452
dosage form
胶囊剂 (Capsule)
administration
Oral
category
Chinese patent medicines
herbs in chinese
红曲
herbs in pinyin
Hong Qu
syndromes in chinese
化浊降脂，活血化瘀，健脾消食
indications in chinese
用于痰阻血瘀所致的高脂血症，症见气短、乏力、头晕、头痛、胸闷、腹胀、食少纳呆；也可用于高脂血症及动脉粥样硬化所致的其他的心脑血管疾病的辅助治疗
indications in english
Used for hyperlipidemia caused by phlegm and blood stasis, symptoms such as shortness of breath, fatigue, dizziness, headache, chest tightness, abdominal distension, lack of appetite and appetite; it can also be used for hyperlipidemia and other heart caused by atherosclerosis Adjuvant treatment of cerebrovascular diseases
source
Chinese Pharmacopoeia 2020 edition
itcm id
53054
🌿 Related Herbs
1 · contains this compound📋 Clinical Trials
1 · subject of clinical studyNCT02057302 A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia
→ Dyslipidemia
📊 Meta-Analyses
3 · systematic reviewCRD42017062739 Chinese patent medicine for hyperlipidemias: a network meta-analysis of randomi
→ Hyperlipidemias, including hypercholesterolemia, h
CRD42017062486 Lipid-lowering effect of Xuezhikang capsule for patients with coronary heart dis
→ Dyslipidemia is a risk for cardiovascular disease.
CRD42019132518 Xuezhikang capsule for hypercholesterolaemia: a systematic review and meta-analy
→ Hypercholesterolemia is a condition characterized
📚 PubMed References
2 · cited researchPMID 29921884 Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the u
Acta Pharmacol Sin
PMID 36126782 The effect of Xuezhikang capsule on gene expression profile in brown adipose tis
J Ethnopharmacol
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables